Literature DB >> 28428481

Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.

Taichirou Morisawa1, Akihiro Nakagomi1, Keiichi Kohashi1, Yoshiki Kusama1, Wataru Shimizu2.   

Abstract

AIMS: Tartrate-resistant acid phosphatase (TRACP)-5b and osteoprotegerin (OPG) are specific and sensitive markers of bone resorption in patients with rheumatoid arthritis (RA) and chronic kidney disease (CKD). The TRACP-5b level is associated with the severity of RA and CKD, while the OPG level is associated with the severity of coronary atherosclerosis and calcification, and can predict a poor outcome in patients with coronary artery disease (CAD). However, the impact of TRACP-5b on coronary atherosclerosis in CAD patients remains unclear.
METHODS: A total of 71 CAD patients (57 men, 14 women; mean age: 69.0±9.7 years) and 28 age- and gender- matched healthy subjects were investigated. The number of diseased vessels (a marker of the severity of coronary atherosclerosis) and the Gensini score (a marker of the extent of coronary atherosclerosis), as well as the OPG and TRACP-5b levels were measured in CAD patients. The TRACP-5b levels were classified into quartiles.
RESULTS: The TRACP-5b levels were significantly higher in CAD patients than in healthy subjects. Patients with higher TRACP-5b levels had higher OPG levels and Gensini scores than those with lower TRACP-5b levels. Higher TRACP-5b levels were associated with an increased number of diseased vessels. A multivariate linear regression analysis showed that the OPG level and the number of diseased vessels or the Gensini score were significantly and independently associated with the TRACP-5b level.
CONCLUSIONS: These data indicate that the TRACP-5b level is significantly associated with the OPG level and with the severity and extent of coronary atherosclerosis in CAD patients.

Entities:  

Keywords:  Coronary artery disease; Gensini score; Number of diseased vessels; Osteoprotegerin; Tartrate-resistant acid phosphatase-5b

Mesh:

Substances:

Year:  2017        PMID: 28428481      PMCID: PMC5656768          DOI: 10.5551/jat.39339

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  37 in total

Review 1.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

2.  Osteoprotegerin: osteo-vascular connection.

Authors:  Toshihiro Tsuruda
Journal:  J Atheroscler Thromb       Date:  2015-02-06       Impact factor: 4.928

Review 3.  Relation between serum osteoprotegerin and carotid intima media thickness in a general population - the Tromsø Study.

Authors:  A Vik; E B Mathiesen; J Brox; T Wilsgaard; I Njølstad; L Jørgensen; J-B Hansen
Journal:  J Thromb Haemost       Date:  2010-10       Impact factor: 5.824

4.  Atherogenic high-fat diet reduces bone mineralization in mice.

Authors:  F Parhami; Y Tintut; W G Beamer; N Gharavi; W Goodman; L L Demer
Journal:  J Bone Miner Res       Date:  2001-01       Impact factor: 6.741

5.  Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.

Authors:  My Svensson; Dag Olav Dahle; Geir Mjøen; Gisela Weihrauch; Hubert Scharnagl; Harald Dobnig; Winfried März; Alan Jardine; Bengt Fellström; Hallvard Holdaas
Journal:  Nephrol Dial Transplant       Date:  2011-12-15       Impact factor: 5.992

6.  Prevalence of chronic kidney disease in the Japanese general population.

Authors:  Enyu Imai; Masaru Horio; Tsuyoshi Watanabe; Kunitoshi Iseki; Kunihiro Yamagata; Shigeko Hara; Nobuyuki Ura; Yutaka Kiyohara; Toshiki Moriyama; Yasuhiro Ando; Shoichi Fujimoto; Tsuneo Konta; Hitoshi Yokoyama; Hirofumi Makino; Akira Hishida; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2009-06-11       Impact factor: 2.801

7.  Osteoporosis and calcification of the aorta.

Authors:  M A Frye; L J Melton; S C Bryant; L A Fitzpatrick; H W Wahner; R S Schwartz; B L Riggs
Journal:  Bone Miner       Date:  1992-11

8.  Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?

Authors:  Susanne Elisabeth Hosbond; Axel Cosmus Pyndt Diederichsen; Lotte Saaby; Lars Melholt Rasmussen; Jess Lambrechtsen; Henrik Munkholm; Niels Peter Rønnow Sand; Oke Gerke; Tina Svenstrup Poulsen; Hans Mickley
Journal:  Atherosclerosis       Date:  2014-07-21       Impact factor: 5.162

9.  Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2.

Authors:  Simone H Mangan; Ann Van Campenhout; Catherine Rush; Jonathan Golledge
Journal:  Cardiovasc Res       Date:  2007-08-02       Impact factor: 10.787

10.  Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease.

Authors:  Taichirou Morisawa; Akihiro Nakagomi; Keiichi Kohashi; Munenori Kosugi; Yoshiki Kusama; Hirotsugu Atarashi; Wataru Shimizu
Journal:  Int Heart J       Date:  2015-11-09       Impact factor: 1.862

View more
  7 in total

1.  Osteoprotegerin/receptor activator of nuclear factor-κB ligand are involved in periodontitis-promoted vascular calcification.

Authors:  Mengyu Jiao; Pengmei Zhang; Xinbo Yu; Pei Sun; Meiwei Liu; Yanya Qiao; Keqing Pan
Journal:  Exp Ther Med       Date:  2022-06-14       Impact factor: 2.751

2.  Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure.

Authors:  Satoshi Abe; Akiomi Yoshihisa; Yasuhiro Ichijo; Yusuke Kimishima; Tetsuro Yokokawa; Tomofumi Misaka; Takamasa Sato; Masayoshi Oikawa; Atsushi Kobayashi; Takashi Kaneshiro; Kazuhiko Nakazato; Yasuchika Takeishi
Journal:  CJC Open       Date:  2020-12-13

3.  Intensive weight gain therapy in patients with anorexia nervosa results in improved serum tartrate-resistant acid phosphatase (TRAP) 5a and 5b isoform protein levels.

Authors:  Christina Patlaka; Bojan Tubic; Pernilla Lång; Staffan Paulie; Diana Swolin-Eide; Per Magnusson; Göran Andersson
Journal:  Eat Weight Disord       Date:  2019-09-17       Impact factor: 4.652

4.  Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI).

Authors:  Elin Chorell; Tommy Olsson; Jan-Håkan Jansson; Patrik Wennberg
Journal:  Metabolites       Date:  2020-12-31

5.  Changes of lipid and bone metabolism in broilers with spontaneous femoral head necrosis.

Authors:  Kangping Liu; Kuanbo Wang; Leguo Wang; Zhenlei Zhou
Journal:  Poult Sci       Date:  2020-11-03       Impact factor: 3.352

6.  Association of circulating microRNA-122 with presence and severity of atherosclerotic lesions.

Authors:  Yu-Long Wang; Wen Yu
Journal:  PeerJ       Date:  2018-07-04       Impact factor: 2.984

7.  A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failure.

Authors:  Iziah E Sama; Rebecca J Woolley; Jan F Nauta; Simon P R Romaine; Jasper Tromp; Jozine M Ter Maaten; Peter van der Meer; Carolyn S P Lam; Nilesh J Samani; Leong L Ng; Marco Metra; Kenneth Dickstein; Stefan D Anker; Faiez Zannad; Chim C Lang; John G F Cleland; Dirk J van Veldhuisen; Hans L Hillege; Adriaan A Voors
Journal:  Eur J Heart Fail       Date:  2020-04-03       Impact factor: 15.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.